1. Home
  2. ESPR vs EXFY Comparison

ESPR vs EXFY Comparison

Compare ESPR & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • EXFY
  • Stock Information
  • Founded
  • ESPR 2008
  • EXFY 2008
  • Country
  • ESPR United States
  • EXFY United States
  • Employees
  • ESPR N/A
  • EXFY N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • ESPR Health Care
  • EXFY Technology
  • Exchange
  • ESPR Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • ESPR 202.2M
  • EXFY 206.1M
  • IPO Year
  • ESPR 2013
  • EXFY 2021
  • Fundamental
  • Price
  • ESPR $1.20
  • EXFY $2.30
  • Analyst Decision
  • ESPR Buy
  • EXFY Strong Buy
  • Analyst Count
  • ESPR 6
  • EXFY 3
  • Target Price
  • ESPR $6.50
  • EXFY $4.75
  • AVG Volume (30 Days)
  • ESPR 3.1M
  • EXFY 1.1M
  • Earning Date
  • ESPR 08-11-2025
  • EXFY 08-07-2025
  • Dividend Yield
  • ESPR N/A
  • EXFY N/A
  • EPS Growth
  • ESPR N/A
  • EXFY N/A
  • EPS
  • ESPR N/A
  • EXFY N/A
  • Revenue
  • ESPR $259,574,000.00
  • EXFY $141,775,000.00
  • Revenue This Year
  • ESPR $4.07
  • EXFY $7.77
  • Revenue Next Year
  • ESPR N/A
  • EXFY $5.45
  • P/E Ratio
  • ESPR N/A
  • EXFY N/A
  • Revenue Growth
  • ESPR 12.99
  • EXFY N/A
  • 52 Week Low
  • ESPR $0.69
  • EXFY $1.45
  • 52 Week High
  • ESPR $3.94
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 63.86
  • EXFY 46.18
  • Support Level
  • ESPR $1.10
  • EXFY $2.41
  • Resistance Level
  • ESPR $1.26
  • EXFY $2.61
  • Average True Range (ATR)
  • ESPR 0.08
  • EXFY 0.15
  • MACD
  • ESPR 0.02
  • EXFY -0.00
  • Stochastic Oscillator
  • ESPR 93.55
  • EXFY 35.13

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: